Selective probes targeting c-MYC Pu22 G-quadruplex and their application in live mice imaging

Zhuo Yu Wenbo Huang Liqiao Shi Shaoyong Ke Shengzhen Xu

Citation:  Zhuo Yu, Wenbo Huang, Liqiao Shi, Shaoyong Ke, Shengzhen Xu. Selective probes targeting c-MYC Pu22 G-quadruplex and their application in live mice imaging[J]. Chinese Chemical Letters, 2022, 33(3): 1627-1631. doi: 10.1016/j.cclet.2021.09.087 shu

Selective probes targeting c-MYC Pu22 G-quadruplex and their application in live mice imaging

English

  • Nucleic acids containing four strands of continuous guanine tend to form an irregular four-stranded structure called G-quadruplex (G4). G4s motifs occur in the promoters of lots of functionally important oncogenes, such as c-MYC, Bcl-2, c-Kit [1-6]. In recent years, G4s has attracted wide attention because of its potential biological function in vivo [7, 8] and its application in the detection of other biomolecules without labeling with fluorescent or luminescent probes [9-12]. The effective detection of G4 structure in living cells will promote the development of telomere targeted anticancer therapy and four-chain specific drugs. The studies of the interaction between G4 DNA and small molecules that bind and stabilize G4s is not only conducive to a better understanding of molecular recognition, but also of great significance for cancer diagnosis and the development of anticancer drugs. Meanwhile, the highly selective fluorescence probes are helpful and indispensable methods to visualize the various biological processes [13-16].

    There are many small molecules have been demonstrated to have the properties of binding to G4s and producing fluorescence [17-37]. These compounds do not produce background fluorescence signal when they are not bound to the analyte, but they emit very significant fluorescence when combined with G4s. Therefore, in the practice of scientific research, if the G4 fluorescence probe with high affinity, high selectivity and high fluorescence intensity can be developed, which can not only enable researchers to better understand the pathogenic mechanism of cancer at the molecular level, but also help to the research and development and improvement of anticancer drugs. Especially, benzothiazole dye Thioflavin T (ThT) has been reported as a typical fluorescent probe of G4 [17-20]. It has been widely used in selective staining and identification of amyloid fibers [21-23] in vivo and in vitro. Mohanty and his colleagues confirmed that ThT can induce human telomere sequence 22AG to form parallel G4 and antiparallel G4 in Tris-Buffer and water, respectively. These two cases produce greater fluorescence enhancement than double-stranded or single-stranded DNA [17]. Thiazole orange (TO1) is also an asymmetric cyanine cationic dye with excellent affinity to G4 [24, 25]. When it is used as a fluorescence probe and the target substance is not detected, its fluorescence is turned off; it has almost no background interference in fluorescence detection, so it is a very popular G4s fluorescent dye, which is widely used in the detection of DNA/RNA with G4 structure. Although TO1 has excellent fluorescence properties, the dye cannot specifically recognize the specific sequence of G4s, so its application value will be greatly reduced.

    In addition, benzothiazolyl group containing nitrogen and sulfur heteroatoms has unique fluorescence properties, which is often regarded as a fluorophore in the discovery of novel probes. It plays an important role in the output of fluorescence signals and the provision of binding sites. Using benzothiazole groups as mother nuclei, the design and synthesis of fluorescent probes with better selectivity [38-45has gradually become a research hotspot in the field of fluorescent probes. Benzothiazole group was first paid attention to because of its important applications in biopharmaceutical [46, 47] and medical diagnosis [48]. Due to the existence of large planar and large delocalized π bonds, benzothiazoles have high fluorescence quantum yields.

    So, based on the aforementioned and the structure of TO1, we designed a series of benzothiazole-guided conjugated systems (BGCS) as shown in Fig. S1 (Supporting information), and hope to discover novel probes with specific recognition for G4 DNA. Through our efforts, it is found that the analogue probe BGCS5 and its derivative BGCS6 have a very strong specific recognition effect on c-MYC Pu22 G-quadruplex sequence. When the probe binds to c-MYC Pu22, it can produce strong red fluorescence. The excitation and emission wavelengths of the compound for confocal microscope imaging are 559 nm and 603 nm, respectively. In addition, the synthesis and structural modification of these benzothiazole-guided conjugated scaffolds are convenient. Because of its good water solubility and great fluorescence intensity, the compound has great application potential in cells and organisms.

    The general synthetic routes of compounds BGCS1–6 were outlined in Scheme 1, and details for the experimental section can be found in Supporting information.

    Scheme 1

    Scheme 1.  Synthetic route for compounds BGCS1–6. Reagents and conditions: (a) Toluene, reflux, overnight; (b) cat. KOH, EtOH, reflux for 4–8 h; (c) 1-methylquinolin-1-ium iodide, cat. KOH, EtOH, reflux.

    The recognition abilities of BGCS1–6 were fully investigated by monitoring the spectra changes of fluorescence in the presence of different equivalents of DNA (Table S1 in Supporting information) separately. First of all, through the analyses of UV–vis absorption spectra for all obtained molecules, we can find that the chemical sensor BGCS5 has a characteristic peak at about 590 nm (Fig. 1A). Only when 1.0 equiv. c-MYC Pu22 was introduced into the buffer (10 mmol/L K2HPO4/KH2PO4 pH 7.0, 100 mmol/L KCl) of BGCS5 (4 µmol/L), a distinct increment of fluorescence was observed (Fig. 1B). These results indicate that BGCS5 can distinguish c-MYC Pu22 from many other DNA species. Subsequently, similar experiments were also carried out for sensor BGCS6, and the same spectral changes were found (Figs. 1C and D). However, the other molecules BGCS1–4 almost no recognition properties at the same test condition (Figs. S2-S5 in Supporting information).

    Figure 1

    Figure 1.  (A, C) Change in UV–vis spectra of BGCS5 and BGCS6 (4 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl), respectively. (B, D) Fluorescence spectra of BGCS5 and BGCS6 (4 μmol/L) (λex = 590 nm) with addition of various analytes (4 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl), respectively.

    Meanwhile, as a typical G4 fluorescent probe, TO1 has a remarkable fluorescence enhancement effect on most G4 sequences. In this test result (Figs. S6 and S7 in Supporting information), there are five tested sequences with fluorescence intensity above 2500, but TO1 has a poor fluorescence enhancement effect on c-MYC Pu22 sequence, with fluorescence intensity below 1000. In the comparison of histograms, the fluorescence intensity of BGCS5 and BGCS6 in the presence of c-MYC Pu22 is close to or exceeds 20, 000 (Fig. S7B), which far exceeds that of TO1. Based on the above results, we believe that the fluorescent probes BGCS5 and BGCS6 have excellent recognition ability for c-MYC Pu22 sequence, and the fluorescence enhancement effect greatly exceeds that of traditional G4 probes. In summary, BGCS5 and BGCS6 have a highly selective detection of c-MYC Pu22 based on the present test results.

    Furthermore, the fluorescence properties of the sensor were explored to establish if the changes in fluorescence could be observable through the 'naked eye' under UV light radiation. It was observed that BGCS5 showed selectivity toward the various DNAs and only the fluorescence color changes under UV light radiation were observed by 'naked eye' experiments induced by c-MYC Pu22 sequence, and the fluorescence color of the solution also quickly changed from colorless to bright red. However, no detectable color responses were observed when adding other analytes such as VEGF, c-Kit1, TBA, TTA, c-Kit2, CGG12, 19AT, dT30. It can also be seen from Fig. 2A that as the number of equivalents of c-MYC Pu22 increases, the color changes were observed in naked-eyes in which the solution changed from pale red to shiny-red. Subsequently, similar phenomenon was also observed for compound BGCS6 (Fig. 2B).

    Figure 2

    Figure 2.  Visualization of BGCS5 and BGCS6 mixed with DNA oligonucleotides under UV light (365 nm).

    In order to investigate the specific concentration for selective DNA and its associated fluorescence changes, the chemosensors BGCS5 and BGCS6 was titrated by successive increment of number of equivalents for c-MYC Pu22 and monitored the fluorescence spectra. From fluorescence titration spectra depicted in Fig. 3, the sensors BGCS5 and BGCS6 showed an obvious peak at 617 nm, the fluorescence bands gradually increased with the addition of increasing equivalents of c-MYC Pu22. No other analytical substrates showed similar changes in maximum excitation wavelength. Moreover, the fluorescence titration experiment also indicated that 1.625 µmol/L and 1.128 µmol/L c-MYC Pu22 G-quadruplex forming DNA oligonucleotide was able to activate fluorescence emission of BGCS5 and BGCS6, respectively.

    Figure 3

    Figure 3.  (A, C) The change of emission peak of BGCS5 and BGCS6 at 617 nm depending on the concentrations of c-MYC Pu22. (B, D) Changes in fluorescence spectra for the chemosensor BGCS5 and BGCS6 (0.8 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl) with sequential addition of c-MYC Pu22 from 0 to 57 μmol/L, respectively.

    In addition, the recognition test was investigated to explain the possible binding mechanism between the sensors (BGCS5 and BGCS6) and c-MYC Pu22, it can be seen that the fluorescence bond at 617 nm was enhanced first and weaker later with the increasing concentration of c-MYC Pu22. The Job-plots (Fig. S8 in Supporting information) indicate a stable 1:1 stoichiometry ratio was formed in the binding complex of the sensor (BGCS5 and BGCS6) and c-MYC Pu22 in the buffer (10 mmol/L K2HPO4/KH2PO4 pH 7.0, 100 mmol/L KCl), and the association constants between c-MYC Pu22 and BGCS5 or BGCS6 is 3.550 × 105 or 2.506 × 105 L/mol, respectively (Fig. S9 in Supporting information). The highly selective recognition for these two molecules may be due to their special structure combined with the large polar unit at one end and the hydrophobic moiety with large steric hindrance at the other end, which can stack with target DNA during the recognition process, and forms a lock-key pairing with the grooves in the G-quadruplex plane. In addition, the special tricycle julolidine scaffold in these two molecules may be more suitable to form π-π stacking, and lead to more conducive to fluorescence.

    To investigate the feasibility of BGCS5 and BGCS6 as a fluorescence probe, their in vitro cytotoxic effects on human melanoma (A875) and human hepatocellular liver carcinoma (HepG2) cell lines were evaluated using the standard MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay [49-51] with 5-fluorouracil (5-FU) as a positive control. The results in Table S2 (Supporting information) indicated that these two probes exhibited very weak cytotoxic effect on the tested cancer cell lines (IC50 > 98 µmol/L), which demonstrated the absence of toxicity of these molecules and might be used as candidates for selective recognition G4s in vivo.

    Based on the aforementioned results, the possible application of in vivo imaging of the sensor was investigated. The compound BGCS5 was dissolved in buffer and injected into mice through tail vein for fluorescence imaging, and the procedures were approved by the Ethics Committee of Hubei Biopesticide Engineering Research Center. The imaging results (Fig. 4) clearly show that in addition to the residual fluorescence in the tail due to intravenous injection, the bright fluorescence mainly appears in the abdominal area of mice, that is, the visceral areas such as liver, stomach, kidney, spleen and so on, which indicates that the genes containing c-MYC Pu22 sequence may mainly exist in animal viscera.

    Figure 4

    Figure 4.  Mice fluorescence imaging using ~100 mW/cm2 590 nm laser excitation and 650LP filter (50 ms exposure time).

    As special nucleic acid structure, G4s have attracted wide attention in different fields. However, it has been a great challenge to find novel ligands or fluorescent probes that can specifically recognize the G4 structure of a specific sequence. In this study, we found that the fluorescence probes BGCS5 and BGCS6 exhibited significant selectivity and strong luminescence response to c-MYC Pu22 over other G4 structure. BGCS5 and BGCS6 showed good biocompatibility to tumor cells (IC50 > 98 µmol/L), and the animal imaging experiments indicate that these two probes have great application prospects in vivo.

    The authors declare no competing financial interest.

    The authors thank Prof. Xuhong Qian (School of Chemistry and Molecular Engineering, East China Normal University) for his helpful advice and encouragement. This work was financially supported by the Innovation and Application of Key Technologies of Quality-improving and Efficiency-increasing of Fengtou Ginger Industry (No. 2020–620–002–06) and Natural Science Foundation of Hubei Province (No. 2020CFB717), and the authors also gratefully acknowledge the partial support from the Program for Leading Talents of Hubei Academy of Agricultural Sciences (No. L2018031) and the Youth Science Foundation of Hubei Academy of Agricultural Sciences (No. 2021NKYJJ17) and Hubei Agricultural Science Innovation centre (No. 2019–620–000–001–27).

    Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2021.09.087.


    1. [1]

      A. Siddiqui-Jain, C.L. Grand, D.J. Bearss, L.H. Hurley, Proc. Natl. Acad. Sci. U. S. A.99 (2002) 11593–11598. doi: 10.1073/pnas.182256799

    2. [2]

      M.L. Bochman, K. Paeschke, V.A. Zakian, Nat. Rev. Genet. 13 (2012) 770–780. doi: 10.1038/nrg3296

    3. [3]

      S. Cogoi, L.E. Xodo, Nucleic Acids Res. 34 (2006) 2536–2549. doi: 10.1093/nar/gkl286

    4. [4]

      H. Fernando, A.P. Reszka, J. Huppert, et al., Biochemistry 45 (2006) 7854–7860. doi: 10.1021/bi0601510

    5. [5]

      K. Cao, P. Ryvkin, F.B. Johnson, Methods 57 (2012) 3–10. doi: 10.1016/j.ymeth.2012.05.002

    6. [6]

      L.H. Hurley, D.D. Von Hoff, A. Siddiqui-Jain, D. Yang, Semin. Oncol. 33 (2006) 498–512. doi: 10.1053/j.seminoncol.2006.04.012

    7. [7]

      R. Rodriguez, K.M. Miller, J.V. Forment, et al., Nat. Chem. Biol. 8 (2012) 301–310. doi: 10.1038/nchembio.780

    8. [8]

      K.W. Zheng, S. Xiao, J.Q. Liu, et al., Nucleic Acids Res. 41 (2013) 5533–5541. doi: 10.1093/nar/gkt264

    9. [9]

      T. Tian, H. Xiao, Z. Zhang, et al., Chem. Eur. J. 19 (2013) 92–95. doi: 10.1002/chem.201203344

    10. [10]

      Y.X. Xiong, Z.S. Huang, J.H. Tan, Eur. J. Med. Chem. 97 (2015) 538–551. doi: 10.1016/j.ejmech.2014.11.021

    11. [11]

      D. Zhao, X.W. Dong, N. Jiang, D. Zhang, C.L. Liu, Nucleic Acids Res. 42 (2014) 11612–11621. doi: 10.1093/nar/gku833

    12. [12]

      V. Brázda, L. Hároníková, J.C.C. Liao, M. Fojta, Int. J. Mol. Sci. 15 (2014) 17493–17517. doi: 10.3390/ijms151017493

    13. [13]

      L. Zhang, D. Duan, Y. Liu, et al., J. Am. Chem. Soc. 136 (2014) 226–233. doi: 10.1021/ja408792k

    14. [14]

      P.P. Jia, L. Xu, Y.X. Hu, et al., J. Am. Chem. Soc. 143 (2021) 399–408. doi: 10.1021/jacs.0c11370

    15. [15]

      X. Luo, Y. Yang, X. Qian, Chin. Chem. Lett. 31 (2020) 2877–2883. doi: 10.1016/j.cclet.2020.07.009

    16. [16]

      Q. Ling, T. Chen, S. Tan, J. Huang, L. Xu, Chin. Chem. Lett. 31 (2020) 2884–2890. doi: 10.1016/j.cclet.2020.08.020

    17. [17]

      J. Mohanty, N. Barooah, V. Dhamodharan, et al., J. Am. Chem. Soc. 135 (2013) 367–376. doi: 10.1021/ja309588h

    18. [18]

      L.L. Tong, L. Li, Z. Chen, Q. Wang, B. Tang, Biosens. Bioelectron. 49 (2013) 420–425. doi: 10.1016/j.bios.2013.05.051

    19. [19]

      V. Gabelica, R. Maeda, T. Fujimoto, et al., Biochemistry 52 (2013) 5620–5628. doi: 10.1021/bi4006072

    20. [20]

      A. Renaud de la Faverie, A. Guedin, A. Bedrat, L.A. Yatsunyk, J.L. Mergny, Nucleic Acids Res. 42 (2014) 1–8. doi: 10.1093/nar/gkt1324

    21. [21]

      P.S. Vassar, C.F. Culling, Arch. Pathol. 68 (1959) 487–498.

    22. [22]

      L.S. Wolfe, M.F. Calabrese, A. Nath, et al., Proc. Natl. Acad. Sci. U.S.A. 107 (2010) 16863–16868. doi: 10.1073/pnas.1002867107

    23. [23]

      M. Biancalana, S. Koide, BBA-Proteins Proteom. 1804 (2010) 1405–1412. doi: 10.1016/j.bbapap.2010.04.001

    24. [24]

      E.V. Dolgosheina, S.C.Y. Jeng, S.S.S. Panchapakesan, et al., ACS Chem. Biol. 9 (2014) 2412–2420. doi: 10.1021/cb500499x

    25. [25]

      L. Unger-Angel, B. Rout, T. Ilani, et al., Chem. Sci. 6 (2015) 5419–5425. doi: 10.1039/C5SC01038A

    26. [26]

      R. Sun, X. Guo, D. Yang, et al., Talanta 226 (2021) 122125. doi: 10.1016/j.talanta.2021.122125

    27. [27]

      T.Y. Tseng, W.W. Chen, I.T. Chu, et al., Sci. Rep. 8 (2018) 16082. doi: 10.1038/s41598-018-34378-8

    28. [28]

      J. Zhao, Z. Yang, Q. Zhai, D. Wei, Anal. Chim. Acta1132 (2020) 93–100. doi: 10.1016/j.aca.2020.07.017

    29. [29]

      Y. Gu, D. Lin, Y. Tang, et al., Spectrochim. Acta A191 (2018) 180–188. doi: 10.1016/j.saa.2017.10.012

    30. [30]

      M. Hu, J. Zhou, W.H. Luo, et al., Anal. Chem. 91 (2019) 2480–2487. doi: 10.1021/acs.analchem.8b05298

    31. [31]

      H. Chen, H. Sun, S. Zhang, et al., Chem. Commun. 55 (2019) 5060–5063. doi: 10.1039/c9cc01263j

    32. [32]

      Z. Yu, W. Luo, X. Chen, et al., Sens. Actuators B: Chem. 324 (2020) 128770. doi: 10.1016/j.snb.2020.128770

    33. [33]

      M. Hu, Sens. Actuators B: Chem. 328 (2021) 128990. doi: 10.1016/j.snb.2020.128990

    34. [34]

      F. Gao, S. Cao, W. Sun, et al., Dyes Pigments171 (2019) 107749. doi: 10.1016/j.dyepig.2019.107749

    35. [35]

      R. Zhang, M. Cheng, L.M. Zhang, L.N. Zhu, D.M. Kong, ACS Appl. Mater. Inter. 10 (2018) 13350–13360. doi: 10.1021/acsami.8b01901

    36. [36]

      Y.J. Lu, D.P. Hu, K. Zhang, W.L. Wong, C.F. Chow, Biosens. Bioelectron. 81 (2016) 373–381. doi: 10.1016/j.bios.2016.03.012

    37. [37]

      M.D. Antonio, A. Ponjavic, A. Radzevičius, et al., Nat. Chem. 12 (2020) 832–837. doi: 10.1038/s41557-020-0506-4

    38. [38]

      V.K. Bhardwaj, P. Saluja, G. Hundal, et al., Tetrahedron 69 (2013) 1606–1610. doi: 10.1016/j.tet.2012.11.090

    39. [39]

      W. Wu, J. Li, L. Chen, et al., Anal. Chem. 86 (2014) 9800–9806. doi: 10.1021/ac502396g

    40. [40]

      M.J. Peng, X.F. Yang, B. Yin, et al., Chem. Asian J. 9 (2014) 1817–1822. doi: 10.1002/asia.201402113

    41. [41]

      L. Liu, Y. Shao, J. Peng, et al., Anal. Chem. 86 (2014) 1622–1631. doi: 10.1021/ac403326m

    42. [42]

      D. Li, Y. Xu, N. Zhou, et al., Dyes Pigments136 (2017) 627–632. doi: 10.1016/j.dyepig.2016.09.014

    43. [43]

      J. Ming, X. Liu, Z. Xin, et al., ACS Appl. Mater. Inter. 10 (2018) 25166–25173. doi: 10.1021/acsami.8b07869

    44. [44]

      J. Wang, S. Qi, J. Du, et al., Chem. J. Chin. Univ. 40 (2019) 1397–1404.

    45. [45]

      P. He, L. Tang, K. Zhong, S. Hou, X. Yan, Chin. J. Org. Chem. 37 (2017) 423–428. doi: 10.6023/cjoc201608003

    46. [46]

      A. Rouf, C. Tanyeli, Eur. J. Med. Chem. 97 (2015) 911–927. doi: 10.1016/j.ejmech.2014.10.058

    47. [47]

      D.C. Liu, H.J. Zhang, C.M. Jin, Z.S. Quan, Molecules 21 (2016) 164. doi: 10.3390/molecules21030164

    48. [48]

      A.K. Mora, S. Murudkar, A. Alamelu, et al., Chem. Eur. J. 25 (2016) 16505–16512. doi: 10.1002/chem.201602981

    49. [49]

      M.C. Alley, D.A. Scudiero, A. Monks, et al., Cancer Res. 48 (1988) 589–601.

    50. [50]

      S. Ke, L. Shi, X. Cao, et al., Eur. J. Med. Chem. 54 (2012) 248–254. doi: 10.1016/j.ejmech.2012.05.003

    51. [51]

      T. Xu, L. Shi, Y. Zhang, et al., Eur. J. Med. Chem. 168 (2019) 293–300. doi: 10.1016/j.ejmech.2019.02.060

  • Scheme 1  Synthetic route for compounds BGCS1–6. Reagents and conditions: (a) Toluene, reflux, overnight; (b) cat. KOH, EtOH, reflux for 4–8 h; (c) 1-methylquinolin-1-ium iodide, cat. KOH, EtOH, reflux.

    Figure 1  (A, C) Change in UV–vis spectra of BGCS5 and BGCS6 (4 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl), respectively. (B, D) Fluorescence spectra of BGCS5 and BGCS6 (4 μmol/L) (λex = 590 nm) with addition of various analytes (4 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl), respectively.

    Figure 2  Visualization of BGCS5 and BGCS6 mixed with DNA oligonucleotides under UV light (365 nm).

    Figure 3  (A, C) The change of emission peak of BGCS5 and BGCS6 at 617 nm depending on the concentrations of c-MYC Pu22. (B, D) Changes in fluorescence spectra for the chemosensor BGCS5 and BGCS6 (0.8 μmol/L) in the buffer (10 mmol/L K2HPO4/KH2PO4, pH 7.0, 100 mmol/L KCl) with sequential addition of c-MYC Pu22 from 0 to 57 μmol/L, respectively.

    Figure 4  Mice fluorescence imaging using ~100 mW/cm2 590 nm laser excitation and 650LP filter (50 ms exposure time).

  • 加载中
计量
  • PDF下载量:  4
  • 文章访问数:  1028
  • HTML全文浏览量:  126
文章相关
  • 发布日期:  2022-03-15
  • 收稿日期:  2021-06-30
  • 接受日期:  2021-09-24
  • 修回日期:  2021-09-15
  • 网络出版日期:  2021-09-30
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

/

返回文章